EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Rapid, portable Epstein‒Barr virus DNA detection using enzymatic recombinase amplification combined with the CRISPR–Cas12a system

Jia Li, Hao Cheng, Xiaojun Wang, Ning Chen, Liujie Chen, Lili Duan, Fenghua Tan, Kai Li, Duanfang Liao, Zheng Hu iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.70028 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Jia Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College of Xiangnan University, the First Affiliated Hospital of Xiangnan University, the First People's Hospital of Chenzhou, Che…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Herpesvirus 4, Human, DNA, Viral. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Science and Technology Program of Hunan Province, Scientific Research Project of Hunan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsHerpesvirus 4, HumanDNA, ViralHumansRecombinasesNucleic Acid Amplification Techniques

Substanzen

DNA, ViralRecombinases

Autor:innen und Institutionen

  • The First Clinical College of Xiangnan University, the First Affiliated Hospital of Xiangnan University, the First People's Hospital of Chenzhou, Chenzhou, China.
  • Translational Medicine Institute, the First People's Hospital of Chenzhou, Hengyang Medical School, University of South China, Chenzhou, China.
  • Department of Nasopharyngeal Carcinoma, the First People's Hospital of Chenzhou, Hengyang Medical School, University of South China, Chenzhou, China.
  • Department of Cancer Center, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • The Oncology Department of the First People's Hospital of Chenzhou, Chenzhou, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Hunan University of Chinese Medicine, Changsha, China.

ORCID-Profile: Zheng Hu

Förderung

  • Natural Science Foundation of Hunan Province
  • Science and Technology Program of Hunan Province
  • Scientific Research Project of Hunan Provincial Health Commission
  • Key Science and Technology Program of Chenzhou
  • Innovative Team Project of the First People's Hospital of Chenzhou
  • Key Project of the First People's Hospital of Chenzhou
  • Special funding fund for clinical research of Wu Jieping Foundation
  • Research Project of Xiangnan University

Zitieren

APA

Li, J., Cheng, H., Wang, X., Chen, N., Chen, L., Duan, L., Tan, F., Li, K., Liao, D., & Hu, Z. (2024). Rapid, portable Epstein‒Barr virus DNA detection using enzymatic recombinase amplification combined with the CRISPR–Cas12a system. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70028

Vancouver

Li J, Cheng H, Wang X, Chen N, Chen L, Duan L, et al. Rapid, portable Epstein‒Barr virus DNA detection using enzymatic recombinase amplification combined with the CRISPR–Cas12a system. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.70028

BibTeX
@article{Li2024,
  author = {Li, Jia and Cheng, Hao and Wang, Xiaojun and Chen, Ning and Chen, Liujie and Duan, Lili and Tan, Fenghua and Li, Kai and Liao, Duanfang and Hu, Zheng},
  title = {Rapid, portable Epstein‒Barr virus DNA detection using enzymatic recombinase amplification combined with the CRISPR–Cas12a system},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.70028}
}
Kostenlos starten →